Sakar Healthcare Limited (NSE:SAKAR)
340.00
+11.45 (3.49%)
Sep 10, 2025, 3:26 PM IST
Sakar Healthcare Revenue
Sakar Healthcare had revenue of 527.36M INR in the quarter ending June 30, 2025, with 28.16% growth. This brings the company's revenue in the last twelve months to 1.89B, up 21.65% year-over-year. In the fiscal year ending March 31, 2025, Sakar Healthcare had annual revenue of 1.78B with 15.19% growth.
Revenue (ttm)
1.89B
Revenue Growth
+21.65%
P/S Ratio
3.92
Revenue / Employee
5.82M
Employees
325
Market Cap
7.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.78B | 234.17M | 15.19% |
Mar 31, 2024 | 1.54B | 199.75M | 14.89% |
Mar 31, 2023 | 1.34B | 50.74M | 3.93% |
Mar 31, 2022 | 1.29B | 338.06M | 35.47% |
Mar 31, 2021 | 953.12M | 113.97M | 13.58% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |